Key Insights

Highlights

Success Rate

91% trial completion (above average)

Published Results

92 trials with published results (37%)

Research Maturity

170 completed trials (68% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

6.4%

16 terminated out of 249 trials

Success Rate

91.4%

+4.9% vs benchmark

Late-Stage Pipeline

8%

21 trials in Phase 3/4

Results Transparency

54%

92 of 170 completed with results

Key Signals

92 with results91% success16 terminated

Data Visualizations

Phase Distribution

225Total
Not Applicable (151)
Early P 1 (4)
P 1 (16)
P 2 (33)
P 3 (5)
P 4 (16)

Trial Status

Completed170
Recruiting20
Terminated16
Unknown14
Withdrawn13
Active Not Recruiting12

Trial Success Rate

91.4%

Benchmark: 86.5%

Based on 170 completed trials

Clinical Trials (249)

Showing 20 of 20 trials
NCT04738825Not ApplicableActive Not RecruitingPrimary

Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management With PrEP Adherence and Support Services

NCT04408313Phase 2Active Not RecruitingPrimary

Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail

NCT04677114Phase 2Completed

Integrated Outpatient Treatment of Opioid Use Disorder and Severe Injection Related Infections

NCT01730781Recruiting

Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

NCT04458545Phase 1RecruitingPrimary

Clinical Trials of Multivalent Opioid Vaccine Components

NCT03787628Phase 2CompletedPrimary

Cannabidiol Effects on Craving and Relapse Prevention in Opioid Use Disorder

NCT05039554Not ApplicableRecruitingPrimary

Randomized Trial of ACT and a Care Management App in Primary Care-based Buprenorphine Treatment

NCT04190563Not ApplicableCompletedPrimary

Pain, Inflammation and Opioid Craving

NCT04245423Not ApplicableCompletedPrimary

The Whole Health Study: Collaborative Care for OUD and Mental Health Conditions

NCT05042388Not ApplicableCompletedPrimary

Mindfulness-Based Relapse Prevention to Improve Medication Assisted Treatment Adherence and Drug-use Outcomes for Opioid Use Disorder

NCT04736550Not ApplicableCompletedPrimary

Enhancing Exercise and Psychotherapy to Treat Pain and Addiction in Opioid Use Disorders ("EXPO" Pilot Trial)

NCT04197921Not ApplicableRecruitingPrimary

Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)

NCT03895827Not ApplicableCompletedPrimary

Recovery Initiation and Management After Overdose (RIMO) Experiment

NCT04069624Not ApplicableActive Not RecruitingPrimary

Kentucky Women's Justice Community Opioid Innovation Network

NCT04379115Not ApplicableRecruitingPrimary

Optimization of NIBS for Treatment of Addiction

NCT05033028Phase 3RecruitingPrimary

Smartphones for Opiate Addiction Recovery

NCT04804072Not ApplicableCompleted

INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit

NCT04927143Not ApplicableRecruitingPrimary

Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives

NCT04783558Not ApplicableActive Not Recruiting

Effective Caregiving for Neonatal Abstinence Syndrome: Testing an Instructional Mobile Technology Platform for High-Risk Pregnant Women

NCT05063201Phase 2CompletedPrimary

Cariprazine for Comorbid Cocaine and Opioid Use Disorder

Scroll to load more

Research Network

Activity Timeline